- ASO Visual Abstract: Clinical Features of Recurrence After Hepatic Resection for Early-Stage Hepatocellular Carcinoma and Long-Term Survival Outcomes of Patients with Recurrence: A Multi-institutional AnalysisYao, Lan-Qing; Chen, Zhen-Liang; Feng, Zi-Han; Diao, Yong-Kang; Li, Chao; Sun, Hai-Ying; Zhong, Jian-Hong; Chen, Ting-Hao; Gu, Wei-Min; Zhou, Ya-Hao; Zhang, Wan-Guang; Wang, Hong; Zeng, Yong-Yi; Wu, Han; Wang, Ming-Da; Xu, Xin-Fei; Pawlik, Timothy M.; Lau, Wan Yee; Shen, Feng; Yang, Tian*Annals of Surgical Oncology, 2022, 29(7): 4306-4307.
- TACE combined with apatinib in patients with intermediate and advanced hepatocellular carcionma: A prospective, multi-center, randomized clinical trialLiang, B.; Ma, Y.; Huang, M.; Zhang, X.; Yu, L.; Luo, Y.; Liu, R.; Zhou, S.; Xu, G.; Li, H-L.; Liao, Z.; Xiang, H.; Lu, W.; Xu, L.; Zheng, C.ESMO Asia Congress, Singapore, SINGAPORE, 2022-12-02 To 2022-12-04.
- Camrelizumab combined with lenvatinib and RALOX-HAIC for hepatocellular carcinoma (HCC) in BCLC stage B and C: A prospective, single-arm, phase II trial (Cal Era study)Zang, M.; Li, Q.; Pang, H.; Hu, X.; Li, R.; Yuan, G.; Li, W.; Guo, Y.; Chen, J.Annual Meeting of the European-Society-for-Medical-Oncology (ESMO), ELECTR NETWORK, 2022-09-09 To 2022-09-13.
会议论文
Huaier granules for hepatocellular carcinoma recurrence after ablation: A multicenter prospective cohort study.
2阅读
